Davis L E, Roth S A, Anderson B
Immunology. 1984 Nov;53(3):435-41.
Animals were immunized with either 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI)-coupled peptide hapten-protein carrier conjugates or with N-acylurea EDCI derived protein carrier. Sera from all animals demonstrated antibody to N-acylurea EDCI when tested by double immunodiffusion using N-acylurea EDCI coupled to a heterologous carrier. Two rabbit antisera, one produced to EDCI-coupled peptide-24-thyroglobulin and another produced to N-acylurea EDCI derived thyroglobulin were further characterized using an enzyme-linked immunosorbent assay (ELISA). Competitive binding assays using either EDCI-coupled peptide-protein conjugates or N-acylurea EDCI derived proteins demonstrated the presence of N-acylurea EDCI reactive antibodies. Such antibodies were also shown to react with the EDCI isourea employed as inhibitor. The specificity of the anti-EDCI antibodies to portions of the EDCI molecule was demonstrated using structural analogues of EDCI. Both 3-dimethylaminopropylamine and 2-dimethylaminoethanol effectively inhibited anti-N-acylurea EDCI reactivity. These results show that when EDCI is used as a coupling agent, antibody is produced to N-acylurea EDCI-carrier, the antibody being primarily directed to the 3-dimethylaminopropyl end of the EDCI molecule.
用1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(EDCI)偶联的肽半抗原-蛋白质载体缀合物或N-酰基脲EDCI衍生的蛋白质载体对动物进行免疫。当使用偶联到异源载体上的N-酰基脲EDCI通过双向免疫扩散进行检测时,所有动物的血清均显示出对N-酰基脲EDCI的抗体。使用酶联免疫吸附测定(ELISA)对两种兔抗血清进行了进一步表征,一种是针对EDCI偶联的肽-24-甲状腺球蛋白产生的,另一种是针对N-酰基脲EDCI衍生的甲状腺球蛋白产生的。使用EDCI偶联的肽-蛋白质缀合物或N-酰基脲EDCI衍生的蛋白质进行的竞争性结合试验证明了存在N-酰基脲EDCI反应性抗体。这种抗体也显示与用作抑制剂的EDCI异脲反应。使用EDCI的结构类似物证明了抗EDCI抗体对EDCI分子部分的特异性。3-二甲基氨基丙胺和2-二甲基氨基乙醇均有效抑制抗N-酰基脲EDCI反应性。这些结果表明,当EDCI用作偶联剂时,会产生针对N-酰基脲EDCI-载体的抗体,该抗体主要针对EDCI分子的3-二甲基氨基丙基末端。